Search

Author/Creator Kleiner, Oliver

2. Evaluation of Pharmacokinetics and Pharmacodynamics of BI 425809, a Novel GlyT1 Inhibitor: Translational Studies. Issue 6 (23rd August 2018)

Authors:
Rosenbrock, Holger; Desch, Michael; Kleiner, Oliver; Dorner‐Ciossek, Cornelia; Schmid, Bernhard; Keller, Sascha; Schlecker, Christina; Moschetti, Viktoria; Goetz, Sophia; Liesenfeld, Karl‐Heinz; Fillon, Gwenaelle; Giovannini, Riccardo; Ramael, Steven; Wunderlich, Glen; Wind, Sven
Journal:
Clinical and translational science
Issue:
Volume 11:Issue 6(2018)
Page Start:
616
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P3‐282: Single oral doses of the novel bace inhibitor bi 1181181 significantly reduce concentrations of cerebrospinal fluid amyloid‐beta peptides in healthy subjects. (1st July 2015)

Authors:
Borta, Andreas; Nicolas, Laurent; Kleiner, Oliver; Kammerer, Klaus-Peter; Schaible, Jennifer; Pietzko, Kerstin; Podhorna, Jana; Dorner-Ciossek, Cornelia; Scholpp, Joachim
Journal:
Alzheimer's & dementia
Issue:
Volume 11(2015)Supplement 7:Part 16
Page Start:
P740
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P3‐283: Pharmacokinetics, pharmacodynamics, and safety of the novel bace inhibitor bi1181181 after oral administration of single ascending doses in healthy subjects. (1st July 2015)

Authors:
Nicolas, Laurent; Kammerer, Klaus-Peter; Schaible, Jennifer; Link, Jasmin; Kleiner, Oliver; Borta, Andreas; Podhorna, Jana; Scholpp, Joachim
Journal:
Alzheimer's & dementia
Issue:
Volume 11(2015)Supplement 7:Part 16
Page Start:
P740
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗